Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda: Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of ...
reuters.com/business/healthcare-pharmaceuticals/merck-raises-2024-profit-forecast-strong-cancer-hpv-drugs-sales-2024-04-25/
Quick Glance: Merck boosts 2024 profit outlook due to Keytruda sales
- Merck & Co. raises annual profit and revenue forecasts based on double-digit growth for the blockbuster cancer drug Keytruda.
- Sales for 2024 are estimated to be between $63.1 billion and $64.3 billion, an increase from the previous forecast.
- Keytruda recorded $6.95 billion in sales in the first quarter, a 20% increase from the previous year.
- Merck also saw strong growth with its vaccine Gardasil, the drug Vaxneuvance, and a successful acquisition of Harpoon Therapeutics in the first quarter of 2024.
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth: Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-collaborate-gene-editing-therapies-with-doudna-founded-mammoth-2024-04-25/
Chanel CEO Says Price Hikes Driven by Inflation, Craftsmanship: Chanel’s chief executive officer defended the luxury brand’s pricing after it raised the cost of ...
bloomberg.com/news/articles/2024-04-25/chanel-ceo-says-price-hikes-driven-by-inflation-craftsmanship
Paid articlePaid
Scholz Gets Another Pharma Boost With New Merck KGaA Site: Merck KGaA became the latest pharma company to begin construction of a new center in Germany ...
bloomberg.com/news/articles/2024-04-25/scholz-gets-another-pharma-boost-with-new-merck-kgaa-site
Petrobras Investors Come Out Ahead After Drama Over Dividends in Brazil: A seven-week tug of war over Petrobras’s dividends wound up with the company delivering ...
bloomberg.com/news/articles/2024-04-25/petrobras-investors-come-out-ahead-after-drama-over-dividends-in-brazil
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
reuters.com/business/healthcare-pharmaceuticals/abbvies-skin-disease-drug-found-be-more-effective-than-regenerons-dupixent-study-2024-04-25/
Starbucks loses appeal over union election at Seattle store: A U.S. appeals court on Wednesday rejected Starbucks' claims that an employee vote to unionize at ...
reuters.com/legal/starbucks-loses-appeal-over-union-election-seattle-store-2024-04-24/
Quick Glance: What Lies Ahead for TikTok in the US?
- The US Senate has unanimously approved a bill that could potentially lead to the banning of TikTok within nine months, unless its Chinese owner, ByteDance, withdraws from the video-sharing app due to concerns about national security threats.
- President Joe Biden has confirmed his intention to sign the legislation on Wednesday.
- ByteDance acquired the well-known karaoke app Musical.ly and rebranded it as TikTok back in 2017. It has become one of the fastest-growing applications in the United States, boasting 150 million monthly subscribers.
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology: GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/glaxosmithkline-sues-pfizer-biontech-over-covid-19-vaccine-technology-2024-04-25/
AstraZeneca leaps after smashing first-quarter forecasts: AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-beats-first-quarter-revenue-profit-estimates-2024-04-25/
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
ft.com/content/f3b5f2e5-1abc-4848-8ff2-66891d5f5984
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy
cnn.com/2024/04/24/health/senate-ozempic-wegovy-price/
Sanofi profit slips on generic competition and currency effects: Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-q1-profit-slips-generic-competition-forex-effects-2024-04-25/
Quick Glance: Sanofi Struggles with Profit Decline due to Competition and Currency Effects
- In the first quarter, Sanofi's operating income decreased by 14.7%, primarily due to currency effects and competitive pressures on their multiple sclerosis drug Aubagio, despite the increase in sales of the anti-inflammatory drug Dupixent.
- The company emphasized the forecast that adjusted earnings per share (EPS) for 2024 are expected to decrease by a low single-digit percentage, excluding currency fluctuations.
- During a media briefing, Finance chief Francois-Xavier Roger highlighted the impact of the decline in the Argentine Peso on first-quarter international sales.
- Since unexpectedly abandoning the 2025 margin targets last October under a plan to boost spending on drug development, CEO Paul Hudson has been working to restore investor confidence in the company's drug pipeline.
Plaintiffs' lawyers chosen to lead Ozempic litigation: A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort ...
reuters.com/legal/litigation/plaintiffs-lawyers-chosen-lead-ozempic-litigation-2024-04-24/
BASF CEO bids farewell with drop in Q1 earnings: Germany's BASF posted a drop in first-quarter adjusted earnings and sales on Thursday ...
reuters.com/business/basf-post-slight-q1-earnings-drop-beats-forecast-2024-04-25/
Puig: Billionaire Owners of Jean Paul Gaultier and Rabanne Plan for IPO: The Puig family is taking its eponymous company public as the next generation won't ...
bloomberg.com/news/articles/2024-04-25/puig-billionaire-owners-of-jean-paul-gaultier-and-rabanne-plan-for-ipo
Paid articlePaid Ad group WPP trails rivals with decline in organic revenue: Britain's WPP became a clear laggard among global ad companies with a drop in organic revenue drop in ...
reuters.com/business/media-telecom/ad-group-wpp-reports-16-drop-first-quarter-organic-growth-2024-04-25/
Haleon names Dawn Allen as CFO: Consumer healthcare firm Haleon said on Wednesday that Dawn Allen has been appointed as its new chief financial officer ...
reuters.com/business/healthcare-pharmaceuticals/haleon-names-dawn-allen-cfo-2024-04-24/
Anne Heche estate cannot settle debts, late actor's son says: Homer Laffoon, Anne Heche's son and the executor of her estate, said in legal documents that his ...
latimes.com/entertainment-arts/story/2024-04-24/anne-heche-estate-debts-homer-laffoon
Quick Glance: Anne Heche's Son Addresses Unpaid Debts in Estate
- Homer Laffoon, Anne Heche's eldest child, is reportedly unable to pay his late mother's debts.
- Heche's estate reportedly consists of a 'modest bank account, royalty payments, and other residual income from pre-death projects,' as well as some business arrangements related to her career and a podcast.
- Despite ongoing appraisals of Heche's assets, at least seven creditors have filed suit against her estate, including Jennifer and John Durand, as well as Lynne Mishele who was living in their house at the time of the crash.
- Laffoon, as the administrator of Heche's estate, expressed optimism that creditor claims can be resolved fairly, but there are challenges due to insufficient funds to settle lawsuits from Heche's accident.
Victoria Beckham’s collaboration with Mango shows how far designer has come: The former Spice Girl’s collection with the high street chain is likely to be a ...
theguardian.com/fashion/2024/apr/23/victoria-beckham-collaboration-high-street-mango
Quick Glance: Victoria Beckham's Evolution Through Collaboration with Mango
- Victoria Beckham has surpassed her aspirations from her Spice Girls days to become a renowned designer, with her collection for Mango showcasing her growth.
- Partnering with Mango allows Beckham to expand her audience and make her brand more accessible to a wider range of consumers.
- Beckham's emphasis on successful collaborations, particularly with Mango, solidifies her position in the fashion industry and highlights her entrepreneurial acumen.
- Her strategic decisions and business successes demonstrate that Beckham continues to thrive as a designer and businesswoman.
Flint, Michigan, residents call on Biden to pay for decade-old federal failures in water crisis
usatoday.com/story/news/nation/2024/04/24/flint-michigan-water-crisis-residents-president-joe-biden/73445933007/
McKinsey Is Under Criminal Investigation for Its Opioid Work: Federal prosecutors are examining the consulting company’s role in helping “turbocharge” the sale ...
nytimes.com/2024/04/24/business/mckinsey-criminal-investigation.html
Quick Glance: Investigation against McKinsey in the US over involvement in the opioid industry
- A grand jury was established to examine evidence related to consulting for pharmaceutical companies involved in the addiction epidemic.
- McKinsey is under a criminal investigation in the US for its involvement with opioid manufacturers.
- Furthermore, federal prosecutors are looking into whether the company impeded justice through its actions as concerns about its work grew.
- According to a source, the US Department of Justice has been scrutinizing McKinsey's activities for several years, with a grand jury now set up in Virginia to review evidence.
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/
McKinsey faces US criminal investigation over its opioids work: McKinsey & Co is under criminal investigation in the United States over allegations that the ...
smh.com.au/business/companies/mckinsey-faces-us-criminal-probe-over-opioids-work-sources-say-20240425-p5fmih.html
US CDC warns of harmful reactions to fake Botox injections: The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted clinicians about risks ...
reuters.com/business/healthcare-pharmaceuticals/us-cdc-warns-harmful-reactions-fake-botox-injections-2024-04-23/
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
cnbc.com/2024/04/24/swiss-pharma-giant-roches-first-quarter-sales-edge-higher-as-its-emerges-from-post-covid-19-slump.html
Bayer CEO is getting rid of bosses: Bayer CEO Bill Anderson may be setting the tone for a new workplace trend.
thestreet.com/employment/bayer-ceo-is-getting-rid-bosses-employees-self-manage
Galderma CEO Says Skincare Firm Can Fix ‘Ozempic Face’ With Fillers: Galderma Group AG’s boss has an answer for people suffering from sunken faces after taking ...
bloomberg.com/news/articles/2024-04-24/we-can-fix-your-ozempic-face-says-skincare-firm
Biogen Alzheimer’s drug sales beat expectations: The Cambridge firm on Wednesday reported a first-quarter profit that exceeded estimates as it cut costs and ...
bostonglobe.com/2024/04/24/business/biogen-alzheimers-drug-leqembi/
Coach Rob Penney tells Crusaders 'be brave, do more': Crusaders coach Rob Penney says he's in a good space and just concentrating on the job in hand.
rnz.co.nz/news/sport/515095/coach-rob-penney-tells-crusaders-be-brave-do-more
'Fulford Road needs more local food stores, not a McDonald's!': 'York's Fulford Road needs more local food stores, not a McDonald's!'
yorkpress.co.uk/news/24274981.fulford-road-needs-local-food-stores-not-mcdonalds-/
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/
Quick Glance: Alzheimer's Drug Uptake Hindered by Doctors' Skepticism in US
- The first drug to slow the progression of Alzheimer's, Leqembi by Eisai and Biogen, is facing resistance in the US from doctors who believe the treatment is futile.
- The requirements of Leqembi, such as additional diagnostic tests, twice-monthly infusions, and regular brain scans, have led to slow adoption as many doctors express concerns about efficacy, cost, and risks.
- Despite FDA approval and proven benefits in clinical trials, many doctors still have reservations about Leqembi, hindering the widespread use of the drug.
- The companies behind Leqembi are working to improve physician and patient education to increase acceptance of the medication, aiming to treat 100,000 patients by 2026.
Solicitor General Elizabeth Prelogar again in the spotlight fighting the conservative Supreme Court on abortion
cnn.com/2024/04/24/politics/solicitor-general-elizabeth-prelogar-idaho-abortion/
Caught on camera: Bucks Co. Taco Bell manager saves choking baby: Surveillance video captured the moment a Taco Bell manager was hailed as a hero after helping ...
nbcphiladelphia.com/news/local/taco-bell-manager-saves-choking-baby/3835775/
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
Sanofi (SAN FP) Asks Banks to Pitch Roles for $20 Billion OTC Spinoff: French drugmaker Sanofi has asked banks to pitch for roles on the separation of its ...
bloomberg.com/news/articles/2024-04-23/sanofi-is-said-to-ask-banks-to-pitch-for-20-billion-otc-spinoff
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reut.rs/3Wbq0wc
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/
Quick Glance: Alzheimer's Drug Uptake Hindered by Doctors' Skepticism in US
- The first drug to slow the progression of Alzheimer's, Leqembi by Eisai and Biogen, is facing resistance in the US from doctors who believe the treatment is futile.
- The requirements of Leqembi, such as additional diagnostic tests, twice-monthly infusions, and regular brain scans, have led to slow adoption as many doctors express concerns about efficacy, cost, and risks.
- Despite FDA approval and proven benefits in clinical trials, many doctors still have reservations about Leqembi, hindering the widespread use of the drug.
- The companies behind Leqembi are working to improve physician and patient education to increase acceptance of the medication, aiming to treat 100,000 patients by 2026.
How Novartis Rode Two Blockbusters To A Three-Day Sprint: Novartis stock jumped Tuesday after the drugmaker topped first-quarter sales and earnings forecasts ...
investors.com/news/technology/novartis-stock-novartis-earnings-q1-2024/
Quick Glance: Positive Quarterly Results Lead to Guidance Increase at Novartis
- Novartis raises its annual guidance following a successful first quarter.
- Revenue increased by 10% to $11.83 billion, with adjusted operating income growing by 16% to $4.54 billion.
- CEO Vas Narasimhan is focusing more on drug development and has been active in mergers and acquisitions.
- Novartis has secured promising drugs, including an experimental prostate cancer drug from Arvinas and the company MorphoSys, which develops cancer treatments, for 2.7 billion euros.
Change Healthcare Finally Admits It Paid Ransomware Hackers—and Still Faces a Patient Data Leak
wired.com/story/change-healthcare-admits-it-paid-ransomware-hackers/
Pendragon owner to cut hundreds of jobs in used car overhaul: New owner of UK dealerships will close second hand marketplace following pandemic-era slump in ...
ft.com/content/42af2045-b7a8-4739-b569-5a22cbac3416
BREAKING: FTSE 100 hits fresh record high at the open as European markets rise www.cnbc.com/2024/04/23/european-markets-live-updates-stocks-news-pmi-data-and-earnings.html
America’s moves against Chinese biotech will hurt patients at home : The motives behind the BIOSECURE act are muddy
economist.com/leaders/2024/04/18/americas-moves-against-chinese-biotech-will-hurt-patients-at-home
MADEMOISELLE J12 LA PAUSA.
Discover the two watches designed by the Watch Creation Studio and donated by CHANEL to the Only Watch charity auction ... Show more www.onlywatch.com/chanel
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents: The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals ...
reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
ft.com/content/1e02c10c-f7c4-48e9-a6a4-774531b56350
Ozempic and Wegovy, the diabetes and weight-loss drugs, have soared to celebrity status in the U.S. But Novo Nordisk, the Danish company behind them ... Show more www.nytimes.com/2024/04/20/business/ozempic-novo-nordisk-wegovy.html
Stay Safe in the Summer Sun: CDC Launches Free Heat Forecast Tool : The CDC has launched an online heat forecaster, HeatRisk Forecast Tool, to help prepare for ...
techtimes.com/articles/303911/20240423/stay-safe-summer-sun-cdc-launches-free-heat-forecast-tool.htm
Africa’s Biggest Drugmaker Aspen Can Help Ease Obesity Medicine Supply Crunch: Africa’s biggest drugmaker could potentially help ease a growing supply crunch for ...
bloomberg.com/news/articles/2024-04-22/africa-s-biggest-drugmaker-aspen-can-help-ease-obesity-medicine-supply-crunch
Pharma groups warn of supply crunch over China spying law: Factory inspectors refuse to visit country over fears they could fall foul of tightened rules
ft.com/content/1d52d75f-5b54-4c27-bdd4-65409f64c64a
Adidas' Next Samba Handball Spezial Overtakes Nike: The company is following its well-worn playbook. But it shouldn’t become over-reliant on one signature ...
bloomberg.com/opinion/articles/2024-04-22/adidas-next-samba-handball-spezial-overtakes-nike
Paid articlePaid
Oncologists' meetings with drug reps don't help cancer patients live longer: Drug company reps commonly visit doctors to talk about new medications ...
npr.org/sections/health-shots/2024/04/22/1246054537/doctor-meetings-drug-reps-pharma-cancer-patients-live-longer-survival
McDonald's scented billboard is a stroke of marketing genius: The billboards don't use a single word or image to advertise McDonald's offerings. Instead ...
trib.al/Ca1V1Nn
Grab a handful of soil or hike a muddy trail – here's why a little bit of dirt is good for your health
cnalifestyle.channelnewsasia.com/wellness/dirt-health-benefits-388821
THROW IT OUT: Time to check your fridge, because you could be putting you and your family at risk with an item that’s been yanked from the shelves due to a ... Show more www.foxbusiness.com/lifestyle/salmonella-prompts-trader-joes-recall-basil-sold-29-states
Markus Kamieth follows Martin Brudermüller: A new era is dawning for BASF: Martin Brudermüller has brought the world's largest chemical company on course for ...
faz.net/aktuell/wirtschaft/markus-kamieth-folgt-auf-martin-brudermueller-fuer-basf-bricht-eine-neue-zeit-an-19666131.html
Paid articlePaid San Francisco Mayor Gives Panda Diplomacy a Try: In a city still struggling to recover from the pandemic, Mayor London Breed hopes giant pandas will lift the ...
nytimes.com/2024/04/22/us/san-francisco-mayor-gives-panda-diplomacy-a-try.html
In an interview, the outgoing CEO complained that Germany had fallen far behind in international comparison.
What is particularly frustrating for him is that ... Show more www.focus.de/finanzen/martin-brudermueller-macht-mich-wuetend-wirtschaftsboss-zaehlt-deutsche-industriepolitik-klar-an_id_259876340.html
Research: More People Use Mental Health Benefits When They Hear That Colleagues Use Them Too
hbr.org/2024/04/research-more-people-use-mental-health-benefits-when-they-hear-that-colleagues-use-them-too
Chipotle Keeps Raising Prices. Gym Rats and Millennials Are Still Buying Burritos.
on.wsj.com/3xPk2ag
When is Earth Day 2024? Why we celebrate the day that's all about environmental awareness
usatoday.com/story/news/nation/2024/04/21/earth-day-2024/73394917007/
Few beauty moments command as much attention as a new nail look from Jennifer Lopez. www.vogue.com/article/jennifer-lopez-manicures
3 Octapharma Plasma centers in Columbus among those across U.S. closed by 'network issues'
dispatch.com/story/news/local/2024/04/19/network-issues-close-octapharma-plasma-centers-in-columbus-and-across-united-states/73377703007/
Adidas' Yeezy boost, Amazon's smart carts, and Starbucks' new cups: Retail roundup
qz.com/adidas-amazon-nike-gamestop-starbucks-best-buy-retail-1851420866
Microsoft buys huge tract south of Atlanta for more data centers: Microsoft made another huge land buy in metro Atlanta for yet another data center complex ...
ajc.com/news/business/microsoft-buys-another-136-acres-south-of-atlanta-to-build-data-centers/QVKCHVK7WZCC7HZUMXHUVQOZWA/
How to fix a faulty microbiome: Our podcast on science and technology. From faecal transplants to microbial medicines, we consider the prospects for a new kind ...
economist.com/podcasts/2024/04/17/how-to-fix-a-faulty-microbiome
Paid articlePaid
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
fortune.com/europe/2024/04/11/pharmaceutical-giant-bayer-ceo-bill-anderson-rid-bosses-staff-self-organize-save-2-billion/
Paid articlePaid
Mexico's Galapagos Islands: Unique Oasis Cuatro Ciénegas Dries Up: The ancient oasis of Cuatro Ciénegas is a unique ecosystem with microorganisms from hundreds ...
n-tv.de/mediathek/bilderserien/panorama/Einzigartige-Oase-Cuatro-Cienegas-trocknet-aus-article24840174.html
America hits Chinese biotech—and its own drugmakers: A sweeping bill in Congress could cost patients at home
economist.com/business/2024/04/15/america-hits-chinese-biotech-and-its-own-drugmakers
WHO likely to issue wider alert on contaminated J&J cough syrup: The World Health Organization is likely to issue a wider warning about contaminated Johnson and ...
reuters.com/business/healthcare-pharmaceuticals/who-says-wider-alert-contaminated-jj-cough-syrup-likely-2024-04-19/
Giannis says he signed with Nike over Adidas because Adidas wasn’t sure if they wanted to offer a contract to his brother Thanasis too.
(via @ThanalysisShow )
These Nail And Hand Care Products Will Make Your Digits Look Perfect: Here’s what’s hands down worth the money — pun intended!
huffpost.com/entry/nail-hand-care-essentials-amazon_l_660ea202e4b083254eab2bc5
BASF boss Brudermüller: Germany is not out of the crisis, it is falling behind: Martin Brudermüller imagined his six years at the helm of the German chemical ...
nzz.ch/wirtschaft/basf-chef-brudermueller-2023-haben-wir-in-allen-maerkten-geld-verdient-ausser-in-deutschland-ld.1826608
Teamwork and a new nickname inspire patient through pancreatic cancer treatment: When he began researching options for pancreatic cancer treatment ...
newsnetwork.mayoclinic.org/discussion/teamwork-and-a-new-nickname-inspire-patient-through-pancreatic-cancer-treatment/
India's Biocon developing its own version of Wegovy, clinical trial likely next year
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
Quick Glance: Biocon Developing Own Version of Wegovy, Plans Clinical Trial
- Indian pharmaceutical company Biocon is working on developing its own version of Novo Nordisk's popular Wegovy and is likely to conduct a clinical trial next year to enter the growing weight-loss drug market.
- Biocon's CEO, Siddharth Mittal, has expressed the company's intention to develop semaglutide, the active ingredient in Wegovy, for the Indian market, even if it requires a clinical trial.
- Biocon aims to introduce generic versions of weight-loss drugs in emerging markets such as Brazil, Mexico, and Saudi Arabia before the patent for semaglutide expires in those countries in 2026.
- The company is striving to obtain a waiver on clinical trials from Indian regulators and submit bioequivalence studies to demonstrate the effectiveness of their version of semaglutide. Biocon is making significant investments in generics research and development, including peptides for weight-loss drugs.
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
cnbc.com/2024/04/20/weight-loss-drug-patients-spend-less-on-restaurants-takeout-survey.html
Tiny, entangled universes that form or fizzle out – a theory of the quantum multiverse | Aeon Videos
aeon.co/videos/tiny-entangled-universes-that-form-or-fizzle-out-a-theory-of-the-quantum-multiverse
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics